Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma

Dr Riccardo Lencioni - University of Pisa, Pisa, Italy
Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma ( Dr Riccardo Lencioni - University of Pisa, Pisa, Italy )
25 Jan 2024

What is new for treatment of soft tissue and bone sarcomas?

Dr Silvia Stacchiotti - The National Cancer Institute of Milan, Italy
What is new for treatment of soft tissue and bone sarcomas? ( Dr Silvia Stacchiotti - The National Cancer Institute of Milan, Italy )
25 Jan 2024

Cancer personomics: Launching the missile - Localised endometrial carcinoma.

Dr Patricia Pautier - Institute Gustave Roussy, Villejuif, France
Cancer personomics: Launching the missile - Localised endometrial carcinoma. ( Dr Patricia Pautier - Institute Gustave Roussy, Villejuif, France )
25 Jan 2024

Novel therapies and combinations in ovarian cancer

Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France
Novel therapies and combinations in ovarian cancer ( Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France )
25 Jan 2024

What's new on ADCs in management of advanced NSCLC

Dr David Planchard - Institute Gustave Roussy, Villejuif, France
What's new on ADCs in management of advanced NSCLC ( Dr David Planchard - Institute Gustave Roussy, Villejuif, France )
25 Jan 2024

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene addiction

Dr Antonio Passaro - European Institute of Oncology, Milan, Italy
Treatment of metastatic NSCLC without PD-L1 expression and without oncogene addiction ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )
25 Jan 2024

Personalised systemic treatment in advanced prostate cancer

Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France
Personalised systemic treatment in advanced prostate cancer ( Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France )
25 Jan 2024

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects

Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )
25 Jan 2024

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

Dr Thierry André - Sorbonne Université, Paris, France
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )
24 Jan 2024

The role of nurses in the fight against cervical cancer in Cameroon

Dr Manjuh Florence - Mboppi Baptist Hospital, Douala, Cameroon
The role of nurses in the fight against cervical cancer in Cameroon ( Dr Manjuh Florence - Mboppi Baptist Hospital, Douala, Cameroon )
19 Jan 2024

Development of AORTIC oncology nursing competencies in sub-Sahran Africa

Dr Naomi Oyoe Ohene Oti - National Radiotherapy Oncology and Nuclear Medicine Centre, Accra, Ghana
Development of AORTIC oncology nursing competencies in sub-Sahran Africa ( Dr Naomi Oyoe Ohene Oti - National Radiotherapy Oncology and Nuclear Medicine Centre, Accra, Ghana )
19 Jan 2024

Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges

Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria
Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges ( Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria )
19 Jan 2024